ClinicalTrials.Veeva

Menu

Pericapsular Nerve Group Block for Elective Hip Arthroplasty

C

Centre Hospitalier Universitaire de Tivoli

Status

Unknown

Conditions

Postoperative Pain

Treatments

Procedure: PENG Block with 0,9% saline
Procedure: PENG Block with local anesthetic

Study type

Interventional

Funder types

Other

Identifiers

NCT04231123
2019-001956-21 (EudraCT Number)
P2019/482

Details and patient eligibility

About

This study examine the effect of Pericapsular Nerve Group (PENG) Block on analgesia after elective hip arthroplasty. Half of participants will receive a PENG Block with local anesthetic, while the other half will receive a PENG Block with a placebo.

Full description

Optimized analgesia is crucial for early mobilization after hip arthroplasty. Regional anesthesia, like fascia iliaca block or femoral nerve block, have limited indication because of motor blockade whereas local infiltrations analgesia have shown conflicting analgesic efficacy results in hip arthroplasty.

Pericapsular nerve group (PENG) block is a new regional anesthesia technique targeting specifically sensory nerve branches of the hip articulation. It has been originally described in hip fracture patients.

The aim of this study is to evaluate the efficacy of PENG block on analgesia after elective hip arthroplasty.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Elective total hip arthroplasty
  • General anesthesia
  • Enhanced Recovery Program

Exclusion criteria

  • American Society of Anesthesiologists (ASA) Score > 2
  • Drug allergy
  • Significant psychiatric disturbances
  • Preoperative opioid use
  • Contraindication to acetaminophen, celecoxib, methylprednisolone or tranexamic acid
  • Body Mass Index > 40 kg/m²

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

60 participants in 2 patient groups, including a placebo group

PENG group
Experimental group
Description:
PENG block with 20 ml of a mixture of 1% Lidocaine with 0,5% Ropivacaine and 1/400.000 Epinephrine
Treatment:
Procedure: PENG Block with local anesthetic
Placebo group
Placebo Comparator group
Description:
PENG block with 20 ml of 0,9% saline
Treatment:
Procedure: PENG Block with 0,9% saline

Trial contacts and locations

1

Loading...

Central trial contact

Nicolas Van Rompaey, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems